MindWalk Holdings Corp. - Common Stock (NQ:HYFT)

MindWalk Holdings Corp. Announces Leadership Update

October 22, 2026

AI Can Design Antibodies Faster Than Anyone Can Check Them for Immune Risk. That Gap Is Starting to Close.

Performance

52-Week Range 61.2% below 52-week high

1.160

0.9952W Low 2.9952W High

1 Week 15.0% below 1-week high

1.101W Low 1.361W High

MindWalk Holdings Corp. - Common Stock (HYFT) traded between $0.99 and $2.99 over the past 52 weeks and last traded at $1.16, 61.2% below its 52-week high. Over the past week it ranged between $1.10 and $1.36.

Past 12 Months

-8.7%

-13.4%

-14.7%

-6.5%

-42.6%

-32.9%

1W -$0.11

1M -$0.18

3M -$0.20

6M -$0.08

YTD -$0.86

1Y -$0.57

HYFT was -32.9% over the past year, -6.5% over six months, -42.6% year to date, -8.7% in the last week.

12 Months vs Market

HYFT

-32.9%

DIA

+10.1%

SPY

+12.3%

QQQ

+14.8%

IWM

+11.9%

Over the past 12 months HYFT returned -32.9% versus DIA (Dow) +10.1%, SPY (S&P 500) +12.3%, QQQ (Nasdaq 100) +14.8% and IWM (Russell 2000) +11.9%.

Volume & Liquidity

170.2K

299.1K

213.6K

290.2K

YTD

350.9K

349.3K

HYFT's 3-month average daily volume is 213.6K.

More News

October 21, 2026

From Wall Street Investor

MindWalk Holdings (NASDAQ:HYFT) Drops After Q4 Revenue Beat, EPS Miss Amid Heavy Commercial Investment ↗

MindWalk Holdings (NASDAQ:HYFT) Falls After Q1 Revenue Miss and Wider Loss ↗

September 14, 2026

Via Chartmill

July 22, 2026

Via Chartmill

MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours

October 21, 2026

AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test

October 14, 2026

From Biotech Insider

MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies

October 14, 2026

Drug Discovery Informatics Market Projected to Reach $7.74 Billion by 2030 as AI Agents Need Biological Context

October 06, 2026

From Equity Insider

MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function

October 06, 2026

MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director

October 01, 2026

Chipmakers Now Ship Protein-Folding AI as Plug-and-Play Microservices

September 22, 2026

From American News Group

MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine

September 21, 2026

MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027

MindWalk (HYFT) Q1 2027 Earnings Call Transcript ↗

September 15, 2026

Via The Motley Fool

MindWalk Q1 Earnings Call Highlights ↗

September 14, 2026

Via MarketBeat

September 14, 2026

MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion

September 14, 2026

MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

September 10, 2026

MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026

September 08, 2026

The Market Just Told You Which Layer Of AI Biology It Is Paying For

September 03, 2026

From Market Updates

Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.

August 19, 2026

From USA News Group

AI Found an Influenza Target That Survives Viral Mutation

August 10, 2026

From Equity Insider

Keep an eye on the top gainers and losers in Friday's session. ↗

July 24, 2026

Via Chartmill

MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI

July 23, 2026